Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Bachmann

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1990
The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolismK A Bachmann, M Nunlee, M Martin, et al.
British Journal of Clinical Pharmacology|February 1, 1986
Inability of ibuprofen to alter single dose phenytoin dispositionK A Bachmann, J I Schwartz, R B Forney, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Drug interactions of H2-receptor antagonistsK A Bachmann, T J Sullivan, L Jauregui, et al.
British Journal of Clinical Pharmacology|October 1, 1993
Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activityK A Bachmann, T J Sullivan, L Jauregui, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patientsJ I Schwartz, L E Jauregui, K A Bachmann, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Short report: a comparative study of the interaction between antacid and H2-receptor antagonistsT J Sullivan, J H Reese, L Jauregui, et al.
Hospital Formulary|March 10, 1989
Optimal dosing of phenytoin: an evaluation of the timing and appropriateness of serum level monitoringP K Wong, D L Brown, K A Bachmann, et al.
Medicine and Science in Sports and Exercise|August 1, 1994
Exercise training does not alter cytochrome P-450 content and microsomal metabolismT J Michaud, K A Bachmann, F F Andres, et al.
Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansJ I Schwartz, C C Chan, S Mukhopadhyay, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1990
The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolismK A Bachmann, M Nunlee, M Martin, et al.
British Journal of Clinical Pharmacology|February 1, 1986
Inability of ibuprofen to alter single dose phenytoin dispositionK A Bachmann, J I Schwartz, R B Forney, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Drug interactions of H2-receptor antagonistsK A Bachmann, T J Sullivan, L Jauregui, et al.
British Journal of Clinical Pharmacology|October 1, 1993
Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activityK A Bachmann, T J Sullivan, L Jauregui, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patientsJ I Schwartz, L E Jauregui, K A Bachmann, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Short report: a comparative study of the interaction between antacid and H2-receptor antagonistsT J Sullivan, J H Reese, L Jauregui, et al.
Hospital Formulary|March 10, 1989
Optimal dosing of phenytoin: an evaluation of the timing and appropriateness of serum level monitoringP K Wong, D L Brown, K A Bachmann, et al.
Medicine and Science in Sports and Exercise|August 1, 1994
Exercise training does not alter cytochrome P-450 content and microsomal metabolismT J Michaud, K A Bachmann, F F Andres, et al.
Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humansJ I Schwartz, C C Chan, S Mukhopadhyay, et al.
Pageof 4